Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
TOMM40/FADS2 Expression Ratio Predicts the Sensitivity to mTOR Inhibitors in Triple‐Negative Breast Cancer
Saved in:
| Published in: | Cancer Medicine |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1871203157597487104 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Cancer Medicine |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:104382 |
| institution | FRELIP |
| journal_source_facet | Cancer Medicine |
| last_indexed | 2026-07-20T03:33:11.357Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | TOMM40/FADS2 Expression Ratio Predicts the Sensitivity to mTOR Inhibitors in Triple‐Negative Breast Cancer Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | TOMM40/FADS2 Expression Ratio Predicts the Sensitivity to mTOR Inhibitors in Triple‐Negative Breast Cancer |
| title_alt | La relación de expresión TOMM40/FADS2 predice la sensibilidad a los inhibidores de mTOR en el cáncer de mama triple negativo Le rapport d'expression TOMM40/FADS2 prédit la sensibilité aux inhibiteurs de mTOR dans le cancer du sein triple négatif A Razão de Expressão TOMM40/FADS2 Prediz a Sensibilidade a Inibidores de mTOR no Câncer de Mama Triplo-Negativo |
| title_auth | TOMM40/FADS2 Expression Ratio Predicts the Sensitivity to mTOR Inhibitors in Triple‐Negative Breast Cancer |
| title_es_txt | La relación de expresión TOMM40/FADS2 predice la sensibilidad a los inhibidores de mTOR en el cáncer de mama triple negativo |
| title_fr_txt | Le rapport d'expression TOMM40/FADS2 prédit la sensibilité aux inhibiteurs de mTOR dans le cancer du sein triple négatif |
| title_full | TOMM40/FADS2 Expression Ratio Predicts the Sensitivity to mTOR Inhibitors in Triple‐Negative Breast Cancer |
| title_fullStr | TOMM40/FADS2 Expression Ratio Predicts the Sensitivity to mTOR Inhibitors in Triple‐Negative Breast Cancer |
| title_full_unstemmed | TOMM40/FADS2 Expression Ratio Predicts the Sensitivity to mTOR Inhibitors in Triple‐Negative Breast Cancer |
| title_pt_txt | A Razão de Expressão TOMM40/FADS2 Prediz a Sensibilidade a Inibidores de mTOR no Câncer de Mama Triplo-Negativo |
| title_short | TOMM40/FADS2 Expression Ratio Predicts the Sensitivity to mTOR Inhibitors in Triple‐Negative Breast Cancer |
| title_sort | tomm40/fads2 expression ratio predicts the sensitivity to mtor inhibitors in triple‐negative breast cancer |
| topic | Oncology General Oncology |
| url | https://onlinelibrary.wiley.com/doi/10.1002/cam4.72089?af=R |